期刊文献+

血小板GPⅡb/Ⅲa受体拮抗剂在冠心病介入治疗中的临床应用现状

原文传递
导出
出处 《中国煤炭工业医学杂志》 2009年第8期1318-1320,共3页 Chinese Journal of Coal Industry Medicine
  • 相关文献

参考文献23

  • 1De Queiroz, Fernandes Araujo JQ, VelosoHH, et al. Efficacy and safety of abcixinabbon acute myocardial infarction treated with percutaneous coronary interventions:a meta- analysis of randomized controlled trials[J~]. Am Heart J, 2004,148 (6) 937- 943.
  • 2Godicke J, Flather M, NocM, et al. Early versus periprocedural administration of abcixinab for primary angioplasty: a pooled analysis of 6 studies[J].Am Heart J,2005,150 (5): 1015.
  • 3Suzuik,Sato K, Kamohara M, et al. Comparative studies of a humanized anti - glycoprotein II b/III a monoclonal antibody, YM337, and abcixiabon invitro antiplatelet effect and binding properties[J]. Biol Pham Bu11,2002,25(8) :1006- 1012.
  • 4唐强,霍勇,陈明,李建平,洪涛,郭来敬,王智,张树和,曲华清.盐酸替罗非班对急性心肌梗死急诊经皮冠状动脉介入治疗中TIMI血流影响的临床研究[J].中国介入心脏病学杂志,2006,14(2):97-99. 被引量:86
  • 5Patel S, Patal M,Din I, et al. Profound thrombocytopenia associated with tirofiban: case report and review of literature[J]. Angioiogy,2005,56(3) :351.
  • 6Corominas N, Perez J, Ortiz J, et al. Tirofihan and eptifibatide treatment of patients presenting with acut coronary syndrome with non- STsegment elevation[J].Parm Word Scj, 2004,26 (1) :38 - 43.
  • 7Robert A, Harrington MD. Randomized, Placebo - controlled trial of titrated intravenous lamifiban for acute coronary syndromes[J]. Circulation 2002,105 :316.
  • 8De Luca G, Suryapranta H, Stone GW, et al. Abciximab as adjunctive therapy to reperfuslon in acute ST- segment elevation myocardial infarction: A meta- analysis of randomized trials[J]. JAM.A,2005,293 (14):1759 - 1765.
  • 9Lavi S,Gruberg L, Kapeliovich M,et al. The impact of GP II b/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients[J]. J Invasive Cardio,2005,17(6):296- 299.
  • 10IMPACT- IT Investigators. Randomizde placebo- controlled trial of effect of eptifibatide on complications of pereutaneous coronary intervention: IMPACT - II [J]. Lancet, 1997, 349 : 1422.

二级参考文献4

  • 1Lefkovitz J,Plow EF,Topol EJ.Platelet glycoprotein Ⅱb/Ⅲa receptor in cardiovascular medicine.N Engl J Med,1995,332:1553-1558.
  • 2Montalescot G,Barragan P,Wittenbery O,et al.For the ADMIRAL investigators.Platelet glycopretion Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction.N Eng J Med,2001,21:1895-1903.
  • 3Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition with tirofiban before primary angioplasty improves angiographic outcome:Results of the Tirofiban give in the Emergency Room before primary angioplasty (TIGER-PA) pilot trial.Circulation,2003,107:1497-1501.
  • 4The TIMI study group.The thrombolysis in myocardial infarction (TIMI) trial;phase I findings.N Engl J Med,1985,312:932-936.

共引文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部